Chengwei Zhang
Papers
3
Total Citations
100
H-Index
2
About
Chengwei Zhang is a leading urologic oncology researcher whose work centers on improving the diagnosis and surgical management of prostate and bladder cancers. His landmark 2017 study comparing 68Ga-PSMA-11 PET-CT with multiparametric MRI for preoperative lymph node staging in intermediate to high-risk prostate cancer—cited 96 times—has significantly advanced preoperative imaging accuracy, guiding more precise surgical planning. Zhang’s contributions extend to artificial intelligence, where his 2024 work on deep neural networks for prostate cancer pathological diagnosis demonstrates exceptional diagnostic accuracy, signaling a transformative shift toward AI-assisted pathology. He has also investigated renal function outcomes following robot-assisted radical cystectomy, revealing that intracorporeal urinary diversion may delay postoperative renal injury—a finding with direct implications for surgical decision-making in bladder cancer patients. With a research portfolio that bridges cutting-edge imaging, AI diagnostics, and minimally invasive surgical techniques, Zhang is shaping the future of precision urologic oncology. His work continues to influence clinical guidelines and inspire further innovation in cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3